| (USD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 6.96B | — |
| Operating expense | — | — |
| Net income | 2.02B | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, GILD returned +30.6% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +20.5% |
| 1 year | +30.6% |
| 5 years | +141.0% |
| 10 years | +165.6% |
| All-time high | $148.95 (Feb 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in GILD would be worth today ›Yes. Gilead Sciences, Inc. paid 4 dividends over the past 12 months. The most recent was $0.82 per share on Jun 15, 2026. The dividend yield is 2.24%.
Gilead Sciences, Inc. stock trades on NASDAQ under the ticker symbol GILD.
Gilead Sciences, Inc. is part of the Healthcare sector.
Gilead Sciences, Inc. has a market cap of 181.18B USD, based on the latest quote.
Gilead Sciences, Inc. is expected to report earnings around Oct 29, 2026. That date is an estimate and has not been confirmed by the company.
